Skip to main content
. 2021 May 3;5:PO.20.00534. doi: 10.1200/PO.20.00534

FIG 2.

FIG 2.

H&E staining (A), 100×, and IHC, (B) for CK20 (+), (C) for Ki-67 (−), and (D) for IHC with D5F3 anti-ALK Ventana antibody showing strong staining and verifying ALK overexpression as a result of EML4-ALK fusion. ALK, anaplastic lymphoma kinase; H&E, hematoxylin and eosin; IHC, immunohistochemistry.